The novel therapy of the medication represents a major advance in the care of diabetes mellitus type 2. Unlike existing medications, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – resulting in https://tirzepatidepeptide689933.blogofchange.com/42751979/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment